Zhejiang Hisyn Pharmaceutical

Zhejiang Hisyn Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and large-scale production of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. As a core subsidiary of Zhejiang Hisun Pharmaceutical, the company operates state-of-the-art manufacturing facilities in Linhai that adhere to stringent global GMP standards, including those of the US FDA and EDQM. Their extensive product portfolio covers critical therapeutic areas such as oncology, cardiovascular health, and infectious diseases, with a notable role in the production of the antiviral Favipiravir. In addition to its own API catalog, Hisyn provides comprehensive CDMO and CMO services, leveraging advanced technologies in chiral synthesis and high-pressure reactions. The company serves a global clientele, supplying essential components to major pharmaceutical firms across North America, Europe, and Asia.